Prevalence and Risk Factors for Functional Vitamin B 12 Deficiency in Patients with Crohn's Disease

Inflammatory Bowel Diseases

Volumn 21, Issue 12, 2015, Pages 2839-2847

  Ward, Mark G ^a   Kariyawasam, Viraj C ^a   Mogan, Sathis B ^a   Patel, Kamal V ^a   Pantelidou, Maria ^a   Sobczyńska Malefora, Agata ^b   Porté, François ^a   Griffin, Nyree ^a   Anderson, Simon H C ^a   Sanderson, Jeremy D ^a,c   Harrington, Dominic J ^b   Irving, Peter M ^a,c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

B12 deficiency; Crohn's disease; holoTC; imaging

Indexed keywords

CYANOCOBALAMIN; BIOLOGICAL MARKER; METHYLMALONIC ACID; TRANSCOBALAMIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; ENTERITIS; EVALUATION STUDY; FEMALE; HUMAN; ILEAL INFLAMMATION; ILEAL RESECTION LENGTH; ILEUM DISEASE; ILEUM RESECTION; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; BLOOD; COMPLICATION; ILEUM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; VITAMIN B 12 DEFICIENCY;

ADULT; BIOMARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; ILEUM; MALE; METHYLMALONIC ACID; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84948185612     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000559     Document Type: Article

References (54)

1. Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, et al. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health. 2012;12:394.
2. Herrmann W, Schorr H, Obeid R, et al. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyper-homocysteinemia in vegetarians. Am J Clin Nutr. 2003;78:131-136.
3. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24:1507-1523.
4. Carmel R. Subtle and atypical cobalamin deficiency states. Am JHematol. 1990;34:108-114.
5. Nygård O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
6. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N EnglJ Med. 2002;346:476-483.
7. Clarke R, Sherliker P, Hin H, et al. Detection of vitamin B12 deficiency in older people by measuring vitamin B12 or the active fraction of vitamin B12, holotranscobalamin. Clin Chem. 2007;53:963-970.
8. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3-32.
9. Hvas AM, Nexo E. Holotranscobalamin-a first choice assay for diagnosing early vitamin B deficiency? J Intern Med. 2005;257:289-298.
10. Carter MJ, Lobo AJ, Travis SPL, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(suppl 5):V1-V16.
11. Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991-1030.
12. Van Assche G, Dignass A, Panés J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis. 2010;4:7-27.
13. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
14. Harvey RF, Bradshaw MJ. Measuring Crohn's disease activity. Lancet. 1980;1:1134-1135.
15. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112-124.
16. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32.
17. Leighton JA, Kane SV, Korzenik JR, et al. M1235 different simple clinical colitis activity index (SCCAI) cut-off points used to define remission of ulcerative colitis (UC) in large mesalamine study. Gastroenterology. 2010;138:S-360.
18. Sobczynska-Malefora A, Gorska R, Pelisser M, et al. An audit of holo-transcobalamin ("Active" B12) and methylmalonic acid assays for the assessment of vitamin B12 status: application in a mixed patient population. Clin Biochem. 2014;47:82-86.
19. Brady J, Wilson L, McGregor L, et al. Active B12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer. Clin Chem. 2008;54:567-573.
20. Lloyd-Wright Z, Hvas AM, Møller J, et al. Holotranscobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem. 2003;49: 2076-2078.
21. Schmedes A, Brandslund I. Analysis of methylmalonic acid in plasma by liquid chromatography-tandem mass spectrometry. Clin Chem. 2006;52:754-757.
22. Vogiatzoglou A, Oulhaj A, Smith AD, et al. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009;55:2198-2206.
23. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999;159:1289-1298.
24. Griffin N, Grant LA, Anderson S, et al. Small bowel MR enterography: problem solving in Crohn's disease. Insights Imaging. 2012;3:251-263.
25. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol. 2001;177:1325-1332.
26. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn's disease. Clin Radiol. 2002;57:913-918.
27. Health Research Authority. Defining Research. Available at: http://www. hra.nhs.uk/documents/2013/09/defining-research.pdf. Accessed November 3, 2014.
28. Battat R, Kopylov U, Szilagyi A, et al. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis. 2014;20:1120-1128.
29. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease. Inflamm Bowel Dis. 2008;14:217-223.
30. Vagianos K, Bernstein CN. Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study. Inflamm Bowel Dis. 2012;18:718-724.
31. Yakut M, Üstün Y, Kabacam G, et al. Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. Eur J Intern Med. 2010;21:320-323.
32. Valente E, Scott JM, Ueland PM, et al. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem. 2011;57: 856-863.
33. Heil SG, de Jonge R, de Rotte MCFJ, et al. Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem. 2012;49: 184-189.
34. Miller JW, Garrod MG, Rockwood AL, et al. Measurement of total vitamin B12 and holotranscobalamin, singly and in combination, in screening for metabolic vitamin B12 deficiency. Clin Chem. 2006;52:278-285.
35. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemi-ologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94:348S-358S.
36. Allen RH, Stabler SP, Savage DG, et al. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90-98.
37. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol. 2006;4:11-20.
38. Carmel R. Holotranscobalamin: not ready for prime time. Clin Chem. 2012;58:643-645; author reply 645-6.
39. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology. 2010;139:1147-1155.
40. Frolkis AD, Dykeman J, Negrón ME, et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145: 996-1006.
41. Thompson WG, Wrathell E. The relation between ileal resection and vitamin B12 absorption. Can J Surg. 1977;20:461-464.
42. Behrend C, Jeppesen PB, Mortensen PB. Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery. Eur J Gastroenterol Hepatol. 1995; 7:397-400.
43. Duerksen DR, Fallows G, Bernstein CN. Vitamin B12 malabsorption in patients with limited ileal resection. Nutrition. 2006;22:1210-1213.
44. Fernandez-Banares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol. 1989;84: 744-748.
45. Coull DB, Tait RC, Anderson JH, et al. Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis. 2007;9:562-566.
46. M'Koma AE, Wise PE, Schwartz DA, et al. Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. Dis Colon Rectum. 2009;52:726-739.
47. Hylander E, Rannem T, Hegnhøj J, et al. Absorption studies after ileal J-pouch anastomosis for ulcerative colitis. A prospective study. Scand J Gastroenterol. 1991;26:65-72.
48. Bernstein CN, Loftus EV, Ng SC, et al. Hospitalisations and surgery in Crohn's disease. Gut. 2012;61:622-629.
49. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250.
50. Lovasz BD, Golovics PA, Vegh Z, et al. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis. 2013;45:269-276.
51. Loukili NH, Noel E, Blaison G, et al. Update of pernicious anemia. A retrospective study of 49 cases [in French]. Rev Med Interne. 2004;25: 556-561.
52. Andres E, Serraj K. Optimal management of pernicious anemia. J Blood Med. 2012;3:97-103.
53. Toh BH, Van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997;337:1441-1448.
54. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology. 1995;45:1435-1440.